Liam Ratcliffe - 27 May 2021 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
27 May 2021
Net transactions value
$0
Form type
4
Filing time
28 May 2021, 17:58:14 UTC
Next filing
10 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Director Stock Option (Right to Buy) Award $0 +16,918 $0.000000 16,918 27 May 2021 Common Stock 16,918 $13.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/12 of the total shares monthly beginning on June 27, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.